Absorption |
Blood-Brain Barrier | BBB- | 0.7717 |
Human Intestinal Absorption | HIA+ | 0.7085 |
Caco-2 Permeability | Caco2- | 0.8778 |
P-glycoprotein Substrate | Substrate | 0.6683 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.8573 |
Non-inhibitor | 0.9222 |
Renal Organic Cation Transporter | Non-inhibitor | 0.8742 |
Distribution |
Subcellular localization | Mitochondria | 0.6483 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.7694 |
CYP450 2D6 Substrate | Non-substrate | 0.8814 |
CYP450 3A4 Substrate | Non-substrate | 0.5563 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.9020 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.9552 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9493 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.9427 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9417 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.8183 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9519 |
Non-inhibitor | 0.7705 |
AMES Toxicity | AMES toxic | 0.9503 |
Carcinogens | Non-carcinogens | 0.9620 |
Fish Toxicity | High FHMT | 0.7815 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9544 |
Honey Bee Toxicity | High HBT | 0.6991 |
Biodegradation | Not ready biodegradable | 0.6544 |
Acute Oral Toxicity | III | 0.6607 |
Carcinogenicity (Three-class) | Non-required | 0.6495 |